Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice

Ankylosing spondylitis is a chronic, progressive disease, and its treatment is relevant to the gut microbiota. Anti‐tumor necrosis factor‐alpha (anti‐TNF‐α) therapy alters the gut microbiota in many diseases, including inflammatory bowel disease. However, little is known about the effect of TNF‐α bl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Microbiologyopen
Autori principali: Liu, Bin, Yang, Lianjun, Cui, Zhifei, Zheng, Junchi, Huang, Jincheng, Zhao, Qinghao, Su, Zhihai, Wang, Min, Zhang, Weicong, Liu, Jinshi, Wang, Tingxuan, Li, Qingchu, Lu, Hai
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6925169/
https://ncbi.nlm.nih.gov/pubmed/31556231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mbo3.927
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi